stella
beta
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer — Stella
Recruiting
Back to Differentiated Thyroid Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Peking Union Medical College Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov